Home > Drug Search >
  • company_query: Araclon Biotech
  •   > 
Drug Filter
Category:
chemistry (8) biology (25)
Status:
Approved (2) Phase Ⅲ (1) Phase Ⅱ (19) Phase Ⅰ (11)
Clinical Stage:
Pending (2) Active (25) Discontinued (4)
Bio-Type:
Gene therapy (1) Cell therapy (1) Vaccine (13) Microbial extract (1) Recombinant enzyme (1) Recombinant cytokines (1) Fusion protein (2)
Indication:
Acute myeloid Leukemia (AML) (1) Alzheimer's disease (AD) (2) Anemia (1) Breast cancer (1) Chronic obstructive pulmonary disease (COPD) (1) Hookworm infections (1) Avian influenza (1) Cystic fibrosis (CF) (1) Herpes simplex virus (1) Hepatocellular carcinoma (HCC) (1) Adult respiratory distress syndrome (ADRS) (1) HIV infection (2) Blepharospasm (1) Glabellar line (1) Equinus foot deformity (1) Rabies (1) Lung cancer (1) Melanoma (2) Ovarian cancer (1) Pancreatic cancer (1) Parkinson's disease (PD) (2) Prostate cancer (1) Psoriasis (1) Norovirus infections (1) Solid tumours (1) Type 2 diabetes (1) Influenza A virus infections (1) Colorectal cancer (1) Influenza B virus infection (1) Pain (1) Stroke (3) Malaria (1) Type 1 diabetes (1) Renal carcinoma (1) Immune-inflammatory diseases (1) Alcoholism (1) Brain injury (1) RSV infection (1) Glioblastoma (1) Glioma (1) Metastatic cancer (1) Brain cancer (1) Muscle spasticity (1) Ebola virus disease (EVD) (2) Spasticity (1)
Others:
Sort: Aprv. Year Alphabetical Prev Next
First Prev 1 2 Next Last GO
Recently Viewed Drugs:
Insert title here
Feed-Back To Top
ICP Permit 14047345| Beijing PSB Hai Dian Record 11010802017043 |(京)-经营性-2015-0023(互联网药品信息服务资格证书)
Insert title here
Feed-Back To Top